ERBB3 Positively Correlates with Intestinal Stem Cell Markers but Marks a Distinct Non Proliferative Cell Population in Colorectal Cancer.
Several studies have suggested ERBB3/HER3 may be a useful prognostic marker for colorectal cancer. Tumours with an intestinal stem cell signature have also been shown to be more aggressive. Here, we investigate whether ERBB3 is associated with intestinal stem cell markers in colorectal cancer and if...
Main Authors: | Thierry Jardé, Lisa Kass, Margaret Staples, Helen Lescesen, Peter Carne, Karen Oliva, Paul J McMurrick, Helen E Abud |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4569358?pdf=render |
Similar Items
-
Patient-Derived Colorectal Cancer Organoids Upregulate Revival Stem Cell Marker Genes following Chemotherapeutic Treatment
by: Rebekah M. Engel, et al.
Published: (2020-01-01) -
The Effect of Diabetes on the Perioperative Outcomes of Colorectal Cancer Surgery Patients.
by: Raymond Yap, et al.
Published: (2016-01-01) -
Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer
by: Christine Koulis, et al.
Published: (2020-03-01) -
Source and Impact of the EGF Family of Ligands on Intestinal Stem Cells
by: Helen E. Abud, et al.
Published: (2021-07-01) -
Age-related islet inflammation marks the proliferative decline of pancreatic beta-cells in zebrafish
by: Sharan Janjuha, et al.
Published: (2018-04-01)